Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02712619Phase 1Completed
Phase 1, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Maximum plasma concentration, Area under the metformin concentration curve and 1 more. Started May 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02712619.